日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Deep-learning-based de novo discovery and design of therapeutics that reverse disease-associated transcriptional phenotypes.

基于深度学习的从头发现和设计能够逆转疾病相关转录表型的治疗方法。

Xing Jing, Tan Mingdian, Leshchiner Dmitry, Sun Mengying, Abdelgied Mohamed, Huang Li, Paithankar Shreya, Uhl Katie, Shankar Rama, Lisabeth Erika, Aleiwi Bilal, Jager Tara, Lawson Cameron, Chen Ruoqiao, Giletto Matthew, Girgis Reda, Neubig Richard R, So Samuel, Ellsworth Edmund, Li Xiaopeng, Chua Mei-Sze, Zhou Jiayu, Chen Bin

A Novel Niclosamide Sulfate Prodrug with Enhanced Bioavailability Suppresses Hepatocellular Carcinoma via Inhibition of Multiple Signaling Pathways

一种新型的尼克酰胺硫酸盐前药具有更高的生物利用度,可通过抑制多种信号通路抑制肝细胞癌。

Tan, Mingdian; Schow, Steve; Liu, Yi; Lum, Robert; Massoudi, Dawiyat; Dhanasekaran, Renumathy; So, Samuel; Chua, Mei-Sze

Magnetic Resonance Imaging Using a Chimeric Anti-Glypican-3 Antibody Conjugated with Gadolinium Selectively Detects Glypican-3-Positive Hepatocellular Carcinoma In Vitro and In Vivo

利用与钆偶联的嵌合抗Glypican-3抗体进行磁共振成像,可选择性地检测体外和体内Glypican-3阳性肝细胞癌

Liu, Yi; Tan, Mingdian; Chua, Mei-Sze; So, Samuel

Identification and validation of microtubule depolymerizing agent, CYT997, as a potential drug candidate for hepatocellular carcinoma.

鉴定和验证微管解聚剂 CYT997 作为肝细胞癌的潜在候选药物

Ahmad Faiz, Ma Li, Wei Wei, Liu Yi, Hakim Isaac, Daugherty Aaron, Mujahid Sana, Radin Andrew A, Chua Mei-Sze, So Samuel

A Humanized Anti-GPC3 Antibody for Immuno-Positron Emission Tomography Imaging of Orthotopic Mouse Model of Patient-Derived Hepatocellular Carcinoma Xenografts

用于原位小鼠模型(患者来源的肝细胞癌异种移植瘤)免疫正电子发射断层扫描成像的人源化抗GPC3抗体

Natarajan, Arutselvan; Zhang, Hui; Ye, Wei; Huttad, Lakshmi; Tan, Mingdian; Chua, Mei-Sze; Gambhir, Sanjiv S; So, Samuel K

Publisher Correction: Harnessing big 'omics' data and AI for drug discovery in hepatocellular carcinoma

出版商更正:利用大型“组学”数据和人工智能进行肝细胞癌药物发现

Chen, Bin; Garmire, Lana; Calvisi, Diego F; Chua, Mei-Sze; Kelley, Robin K; Chen, Xin

Harnessing big 'omics' data and AI for drug discovery in hepatocellular carcinoma

利用大数据组学和人工智能进行肝细胞癌药物研发

Chen, Bin; Garmire, Lana; Calvisi, Diego F; Chua, Mei-Sze; Kelley, Robin K; Chen, Xin

An NIR-II/MR dual modal nanoprobe for liver cancer imaging

一种用于肝癌成像的近红外二区/磁共振双模纳米探针

Ren, Ying; He, Shuqing; Huttad, Lakshmi; Chua, Mei-Sze; So, Samuel K; Guo, Qiyong; Cheng, Zhen

Correction: SOCS5 inhibition induces autophagy to impair metastasis in hepatocellular carcinoma cells via the PI3K/Akt/mTOR pathway

更正:SOCS5抑制通过PI3K/Akt/mTOR通路诱导自噬,从而抑制肝细胞癌细胞的转移。

Zhang, Mao; Liu, Shihai; Chua, Mei-Sze; Li, Haoran; Luo, Dingan; Wang, Sheng; Zhang, Shun; Sun, Chuandong; Han, Bing

Suppression of ATAD2 inhibits hepatocellular carcinoma progression through activation of p53- and p38-mediated apoptotic signaling

抑制ATAD2可通过激活p53和p38介导的细胞凋亡信号通路抑制肝细胞癌的进展。

Lu, Wen-Jing; Chua, Mei-Sze; So, Samuel K